AI-Enhanced OCT Trial Opens: Pre-Surgical Margin Detection for Basal Cell Carcinoma — Potential to Reduce Mohs Surgery Stages

References

1. 1.Australian Institute of Health and Welfare. (2023). Cancer in Australia 2023. AIHW Cancer Series CAN-144. https://www.aihw.gov.au/reports/cancer/cancer-in-australia-2023
2. 2.Connolly, S. M., Baker, D. R., Coldiron, B. M., Fazio, M. J., Storrs, P. A., Vidimos, A. T., Zalla, M. J., Brewer, J. D., Smith Begolka, W., & Berger, T. G. (2012). AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: A report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery. Journal of the American Academy of Dermatology, 67(4), 531-550. https://doi.org/10.1016/j.jaad.2012.06.009
3. 3.Henry Ford Health System. (2024). Artificial Intelligence Enhanced Optical Coherence Tomography (AI-OCT) Imaging for Pre-surgical Margin Detection of Basal Cell Carcinoma. ClinicalTrials.gov NCT07358637. https://clinicaltrials.gov/study/NCT07358637
4. 4.Olsen, C. M., Green, A. C., Neale, R. E., Webb, P. M., Cicero, R. A., Jackman, L. M., O'Brien, L., Perry, S. L., Rankin, N. M., Whiteman, D. C., & QSkin Study. (2019). Cohort profile: the QSkin Sun and Health Study. International Journal of Epidemiology, 48(2), 381-381j. https://doi.org/10.1093/ije/dyy170
5. 5.Ulrich, M., Lange-Asschenfeldt, S., & Gonzalez, S. (2022). In vivo reflectance confocal microscopy for early diagnosis of nonmelanoma skin cancer. Acta Dermato-Venereologica, 102, adv00688. https://doi.org/10.2340/actadv.v102.2127